Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0486 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0486 | 0.0316 | 1 |
Trypanosoma cruzi | phosphatidylinositol 3-related kinase, putative | 0.0486 | 0.0316 | 0.0978 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0486 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0486 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0486 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0486 | 0.0316 | 1 |
Echinococcus granulosus | hypothetical protein | 0.0868 | 0.0885 | 0.0885 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0486 | 0.0316 | 0.2434 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0486 | 0.0316 | 0.8153 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0486 | 0.0316 | 1 |
Trypanosoma brucei | phosphatidylinositol 3-kinase, putative | 0.0486 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0486 | 0.0316 | 1 |
Schistosoma mansoni | biogenic amine (5HT) receptor | 0.0489 | 0.032 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0486 | 0.0316 | 1 |
Echinococcus granulosus | biogenic amine 5HT receptor | 0.0489 | 0.032 | 0.032 |
Echinococcus multilocularis | conserved hypothetical protein | 0.0833 | 0.0833 | 0.0833 |
Toxoplasma gondii | non-specific serine/threonine protein kinase | 0.0306 | 0.0047 | 0.1478 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0486 | 0.0316 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.2442 | 0.3232 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0306 | 0.0047 | 0.1478 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0486 | 0.0316 | 1 |
Echinococcus multilocularis | biogenic amine (5HT) receptor | 0.0489 | 0.032 | 0.032 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0486 | 0.0316 | 1 |
Brugia malayi | Dopamine receptor protein 1 | 0.0534 | 0.0388 | 0.2986 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0486 | 0.0316 | 1 |
Trypanosoma brucei | target of rapamycin kinase 3, putative | 0.0486 | 0.0316 | 1 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0486 | 0.0316 | 0.8153 |
Trypanosoma brucei | phosphatidylinositol 3-related kinase, putative | 0.0486 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0486 | 0.0316 | 1 |
Trypanosoma brucei | Phosphatidylinositol 3-kinase tor1 | 0.0486 | 0.0316 | 1 |
Toxoplasma gondii | target of rapamycin (TOR), putative | 0.0486 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0486 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0486 | 0.0316 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0306 | 0.0047 | 0.1478 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0486 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0486 | 0.0316 | 1 |
Echinococcus granulosus | phosphatidylinositol 3 and 4 kinase | 0.0486 | 0.0316 | 0.0316 |
Echinococcus multilocularis | phosphatidylinositol 3 and 4 kinase | 0.0486 | 0.0316 | 0.0316 |
Giardia lamblia | GTOR | 0.0486 | 0.0316 | 0.5 |
Brugia malayi | Serotonin receptor | 0.1146 | 0.1299 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0486 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0486 | 0.0316 | 1 |
Entamoeba histolytica | FKBP-rapamycin associated protein (FRAP), putative | 0.0486 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0486 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0486 | 0.0316 | 1 |
Echinococcus granulosus | FKBP12 rapamycin complex associated protein | 0.0486 | 0.0316 | 0.0316 |
Schistosoma mansoni | phosphatidylinositol 3-and 4-kinase | 0.0486 | 0.0316 | 0.9879 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0486 | 0.0316 | 1 |
Leishmania major | hypothetical protein, conserved | 0.2535 | 0.3371 | 1 |
Trypanosoma brucei | phosphatidylinositol 4-kinase, putative | 0.0486 | 0.0316 | 1 |
Echinococcus multilocularis | DNA dependent protein kinase catalytic subunit | 0.6982 | 1 | 1 |
Trypanosoma brucei | FAT domain/Rapamycin binding domain/Phosphatidylinositol 3- and 4-kinase, putative | 0.0306 | 0.0047 | 0.1478 |
Entamoeba histolytica | phosphatidylinositol3-kinaseTor2, putative | 0.0486 | 0.0316 | 1 |
Schistosoma mansoni | ataxia telangiectasia mutated (atm)-related | 0.0486 | 0.0316 | 0.9879 |
Trypanosoma cruzi | Phosphatidylinositol 3-kinase tor2 | 0.0486 | 0.0316 | 0.0978 |
Loa Loa (eye worm) | hypothetical protein | 0.0534 | 0.0388 | 1 |
Trypanosoma cruzi | phosphatidylinositol 3-related kinase, putative | 0.0486 | 0.0316 | 0.0978 |
Echinococcus multilocularis | FKBP12 rapamycin complex associated protein | 0.0486 | 0.0316 | 0.0316 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0486 | 0.0316 | 1 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0486 | 0.0316 | 0.2434 |
Loa Loa (eye worm) | hypothetical protein | 0.0306 | 0.0047 | 0.1205 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0486 | 0.0316 | 1 |
Trypanosoma cruzi | target of rapamycin kinase 3 | 0.0486 | 0.0316 | 0.0978 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0486 | 0.0316 | 1 |
Trypanosoma cruzi | Phosphatidylinositol 3-kinase tor1 | 0.0486 | 0.0316 | 0.0978 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0486 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0486 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0486 | 0.0316 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Ki (binding) | = 9.4 nM | Displacement of [3H]N-methylspiperone from rat dopamine D4 receptor by liquid scintillation counting | ChEMBL. | 25070422 |
Ki (binding) | = 9.7 nM | Displacement of [3H]N-methylspiperone from human dopamine D3 receptor by liquid scintillation counting | ChEMBL. | 25070422 |
Ki (binding) | = 33 nM | Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting | ChEMBL. | 25070422 |
Ki (binding) | = 102 nM | Displacement of [3H] 8-OH-DPAT from human 5-HT1A receptor by liquid scintillation counting | ChEMBL. | 25070422 |
Ki (binding) | = 317 nM | Displacement of [3H]Ketanserin from human 5-HT2A receptor by liquid scintillation counting | ChEMBL. | 25070422 |
Ki (binding) | = 414 nM | Displacement of [3H]Citalopram from human Serotonin transporter by liquid scintillation counting | ChEMBL. | 25070422 |
Ki (binding) | = 472 nM | Displacement of [3H]LSD from human 5-HT7 receptor by liquid scintillation counting | ChEMBL. | 25070422 |
Ki (binding) | = 778 nM | Displacement of [3H]GBR12935 from human dopamine transporter by liquid scintillation counting | ChEMBL. | 25070422 |
Ki (binding) | = 1381 nM | Displacement of [3H]LSD from human 5-HT2B receptor by liquid scintillation counting | ChEMBL. | 25070422 |
Ki (binding) | = 1719 nM | Displacement of [3H]Pyrilamine from human histamine H1 receptor by liquid scintillation counting | ChEMBL. | 25070422 |
Ki (binding) | = 2434 nM | Displacement of [3H]Mesulergine from rat 5-HT2C receptor by liquid scintillation counting | ChEMBL. | 25070422 |
Ki (binding) | > 10000 nM | Displacement of [3H]SCH23390 from human dopamine D1 receptor by liquid scintillation counting | ChEMBL. | 25070422 |
Ki (binding) | > 10000 nM | Displacement of [3H]SCH23390 from human dopamine D5 receptor by liquid scintillation counting | ChEMBL. | 25070422 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.